 |
|
monoclonal antibody CC49-delta CH2
A humanized CH2 domain-deleted second-generation monoclonal antibody based on the antibody B72.3 that is directed against tumor-associated glycoprotein 72 (TAG72). TAG72 is expressed by gastric, breast, pancreatic, colorectal, and ovarian carcinoma cells. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonyms: | | MOAB HCC49DCH2
MoAb HuCC49DeltaCH2
Monoclonal Antibody HCC49DCH2 | | | | Abbreviation: | | MOAB CC49-deltaCH2 | | |
|
|
